US 12,357,207 B2
Sensor for a continuous biological monitor having nitric oxide releasing compound
Qinyi Yan, San Diego, CA (US); Robert James Boock, Carlsbad, CA (US); Jessie Haskamp, San Diego, CA (US); and Huashi Zhang, San Juan Capistrano, CA (US)
Assigned to Allez Health Inc., Carlsbad, CA (US)
Filed by Allez Health Inc., Carlsbad, CA (US)
Filed on Aug. 9, 2023, as Appl. No. 18/447,222.
Application 18/447,222 is a continuation of application No. 17/457,004, filed on Nov. 30, 2021, granted, now 11,813,059.
Prior Publication US 2023/0380735 A1, Nov. 30, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/145 (2006.01); A61B 5/1486 (2006.01); A61B 5/265 (2021.01); A61B 5/266 (2021.01); A61B 5/268 (2021.01)
CPC A61B 5/14865 (2013.01) [A61B 5/14532 (2013.01); A61B 5/265 (2021.01); A61B 5/266 (2021.01); A61B 5/268 (2021.01); A61B 2562/125 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A subcutaneous sensor comprising:
a working electrode of the subcutaneous sensor for use with a continuous glucose monitor; and
a reference electrode of the subcutaneous sensor comprising:
a reference substrate;
an ion limiting layer over the reference substrate; and
a composition for releasing nitric oxide (NO), the composition having a NO release compound, a hydrophilic material and a hydrophobic material.